Your Position: Home > News > Company News > Novartis AG Became ELISA kits customer of Meretciel

Novartis AG Became ELISA kits customer of Meretciel




Meretciel has provided Monkey sCD40std ELISA Kits for Novartis AG  since 2013.  The ELISA kits have been provided to Novartis AG for R&D.Novartis AG (NYSE: NVS) headquartered in Basel, Switzerland, has 98,000 employees worldwide and operations in more than 140 countries around the world.Novartis is committed to maintaining health, treat diseases and improve the quality of life,in leading position of the global pharmaceutical industry,among the 168 of the world's top 500 enterprises  in 2007. Novartis  focus on the growing field of healthcare, with innovative medicines, prophylactic vaccines and diagnostic reagents, as well as the consumer healthcare products such as diversified business portfolio ,in order to best meet the needs of patients and societies. Novartis is the only company in the above four areas are in a leading position.


Meretciel is one of the core brands of  Putus Macromolecular Sci. & Tech.Ltd. We offer kits, reagents, service and technical support that enable researchers and clinicians to test and diagnose molecules and proteins of interest. MER & CIEL has prepared and commercialized over thousands of antigens and antibodies of high purity and specificity.  Presently we offer highly specific monoclonal and polyclonal antibodies, antibody pairs, and high quality ELISA kits. We also offer software for massive data analysis of ELISA.  We provide professional service and technical support to our customers.


We are honored to announce that Novartis AG has become the customer of Meretciel in September 2013.  Meretciel will continuously and persistently provide excellent-quality ELISA kits for all of our customers.

For more information of us, please visit the following links:



Contact Us | About Us | Delivery | Feedback
Putus Macromolecular Sci. & Tech. Ltd All Rights Reserved. ©Copyright2012
Room7038, Hi-tech tower, Huaguang Road 18, East Lake New Technology Development Zone Tel: +86(0) 27 87610995 E-mail:
Skype Skype